Moriah Partners

Moriah Partners is a U.S.-based private equity investment firm rather than an operating biotech or pharmaceutical company. The firm focuses on control equity investments, turnarounds, and emerging growth companies, with healthcare listed among its preferred industries alongside security and sports. Its healthcare activity appears to be investment- and services-oriented, with an emphasis on software, content, and services businesses rather than development of therapeutic products. Moriah Partners promotes a proprietary investment methodology called the Moriah Process and has been associated with healthcare-focused executives including managing partner Jacqueline Kosecoff. For biotech analyst purposes, it is best classified as a healthcare-focused investor, not a drug developer.